Healthy volunteers test cystic fibrosis Drug's effect on cholesterol med
NCT ID NCT07349394
First seen Jan 19, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looked at how a cystic fibrosis drug combination (vanzacaftor/tezacaftor/deutivacaftor) affects the levels of a common cholesterol drug (rosuvastatin) in the body. 18 healthy adults took both medications, and researchers measured drug levels and checked for side effects. The goal was to understand potential drug interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Altasciences - Kansas City
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.